Teens Benefit From Bariatric Surgery, Regardless of Weight Loss
FRIDAY, Dec. 4, 2020 -- Remission of obesity-associated complications (OACs) is not dependent on major sustained weight loss in teens undergoing metabolic and bariatric surgery (MBS), according to a study published online Nov. 24 in Obesity.
S. Christopher Derderian, M.D., from University of Colorado at Aurora, and colleagues used data from the Teen Longitudinal Assessment of Bariatric Surgery to assess the relationship between weight loss and remission of OACs after MBS in adolescents. The analysis included adolescents with severe obesity who underwent MBS between 2007 and 2012 with five years of follow-up data. Lower weight-loss responders (LWLRs) were defined as having <20 percent total body weight loss (TBWL) and higher weight-loss responders (HWLRs) had ≥20 percent TBWL.
The researchers found that both LWLRs (114 adolescents) and HWLRs (78 adolescents) lost significant weight within the first year following MBS. However, TBWL at five years was 8.6 percent for the LWLRs and 33.8 percent for the HWLRs. At five years, HWLRs were more likely to experience durable remission of composite dyslipidemia. There were no differences in remission rates for all other OACs.
"In looking at the relationship between the extent of weight loss and health benefits obtained, it is clear that patients' health improves regardless of whether or not they sustain high levels of weight loss long-term following surgery," a coauthor said in a statement.
Two authors disclosed financial ties to the pharmaceutical and biopharmaceutical industries.
© 2021 HealthDay. All rights reserved.
Posted: December 2020
Read this next
THURSDAY, Jan. 14, 2021 -- Patients with type 2 diabetes adhering to low-carbohydrate diets (LCDs) for six months may experience greater rates of diabetes remission, according to...
WEDNESDAY, Jan. 13, 2021 -- New patient visit volumes decreased across the board at a comprehensive metabolic and weight loss center during the COVID-19 pandemic, but follow-up...
MONDAY, Jan. 11, 2021 -- Higher body mass index (BMI) is associated with a significantly increased risk for colorectal cancer (CRC) among men, whereas higher waist-to-hip ratio...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.